Veritas In Silico Inc.

Veritas In Silico Inc. is a biotechnology company engaged in small molecule drug discovery and nucleic acid drug discovery targeting mRNA. It has a commercialization agreement with Liverpool ChiroChem for mRNA-targeted drug discovery and development. The company was incorporated in 2016 and is based in Shinagawa, Japan.